首页|期刊导航|新医学|过表达EP4基因的人CD34+细胞构建及EP4A对其在小鼠体内的归巢影响

过表达EP4基因的人CD34+细胞构建及EP4A对其在小鼠体内的归巢影响OA

Construction of human CD34+cells overexpressing the EP4 gene and preliminary observation of the impact of EP4A on their homing in mice

中文摘要英文摘要

目的 通过构建前列腺素 E受体 4(EP4)基因过表达慢病毒载体,将外源性 EP4 基因克隆至人 CD34+细胞中;观察过表达 EP4 基因的人 CD34+细胞在小鼠体内的归巢现象,初步探讨 EP4 受体激动剂(EP4A)对人 CD34+细胞在小鼠体内归巢效应的影响.方法 ①采用化学方法合成 EP4-cDNA 片段,将其克隆至 GL107质粒载体中,构建GL107-EP4+质粒.②通过 293T细胞将其包装成 GL107-EP4+慢病毒,同时包装 GL107慢病毒作为阴性对照.③用上述慢病毒感染人 CD34+细胞,通过倒置荧光显微镜观察慢病毒感染效果,流式检测慢病毒感染效率,定量逆转录聚合酶链反应(qRT-PCR)、蛋白质印迹(Western blot)检测 EP4 基因表达情况.④活体成像观察 EP4A 对 EP4+-人 CD34+细胞在小鼠体内归巢效应的影响及确定适宜观察时间.⑤免疫组化检测 EP4A 刺激后人 CD34+细胞输注小鼠的骨髓组织中 EP4 分子的表达情况.⑥qRT-PCR和 Western blot检测上述小鼠骨髓细胞中 CXC家族趋化因子受体 4(CXCR4)的表达情况.结果 ①DNA测序证实 GL107-EP4+质粒中的 EP4-cDNA序列正确.②GL107-EP4+质粒能通过 293T 细胞包装成慢病毒,病毒滴度大于 1×108 TU/mL.③荧光显微镜观察到 GL107-EP4+及 GL107慢病毒感染的人 CD34+细胞的 GFP 荧光强度比未感染慢病毒的人 CD34+细胞(背景对照)增强;流式检测 GL107-EP4+和 GL107慢病毒感染效率分别为 28.06%和66.76%.GL107-EP4+组的 EP4 信使 RNA(mRNA)及蛋白表达高于背景对照及 GL107慢病毒感染组(0.580±0.032 vs.0.256±0.027 vs.0.250±0.043,均 P<0.001).④移植后第 3天为 EP4A 促进 EP4+-人 CD34+细胞归巢效应的适宜观察时间(P<0.05).⑤移植后 EP4A刺激组的骨髓组织 EP4 的相对表达量较未刺激组(EP4+-Luc)高(0.164±0.004 vs.0.118±0.007,P=0.016).⑥EP4A 刺激组的 CXCR4 mRNA 及蛋白表达均高于对照组(均 P<0.05).结论 EP4 基因可成功克隆至人 CD34+细胞,且 EP4 蛋白可成功过表达.EP4A可能通过促进 CXCR4 表达,提高人 CD34+造血细胞向受体小鼠骨髓组织中的定向归巢效率.

Objective To construct a lentiviral vector for over-expressing the prostaglandin E receptor 4(EP4)gene,clone the exogenous EP4 gene into human CD34+cells,observe the homing of these EP4 gene over-expressing cells in mice,and preliminarily investigate the effect of the EP4-specific agonist(EP4A)on this homing.Methods ①An EP4-cDNA fragment was chemically synthesized and cloned into a GL107 plasmid to construct the GL107-EP4+plasmid.②The GL107-EP4+plasmid and a control GL107 plasmid were packaged into lentiviruses using 293T cells.③Human CD34+cells were infected with these lentiviruses.Infection efficiency was assessed via fluorescence microscopy and flow cytometry,while EP4 expression was detected by qRT-PCR and Western blot.④The effect of EP4A on the homing of EP4+-human-CD34+cells in mice and the determination of the appropriate observation time was observed using in vivo imaging.⑤Detect the expression of EP4 in the bone marrow of mice after human CD34+cells were transfused by immunohistochemistry after EP4A stimulation.⑥CXCR4 expression in the bone marrow cells of these mice was measured by qRT-PCR and Western blot.Result ①DNA sequencing confirmed the correct EP4-cDNA sequence in the GL107-EP4+plasmid.②The GL107-EP4+plasmid was successfully packaged into lentiviruses with a titer>1×108TU/mL.③Fluorescence microscopy observed that the GFP fluorescence intensity of GL107-EP4+and GL107 lentivirus-infected human CD34+cells was enhanced compared to the background control(uninfected lentivirus human CD34+cells);flow cytometry detected the infection efficiency of GL107-EP4+and GL107 lentivirus as 28.06%and 66.76%,respectively.The expression of EP4 messenger RNA(mRNA)and protein in GL107-EP4+was higher than in background control and GL107 lentivirus groups(0.580±0.032 vs.0.256±0.027 vs.0.250±0.043,both P<0.001).④Day 3 post-transplantation was identified as the appropriate observation time for the EP4A-enhanced homing effect(P<0.05).⑤The relative expression level of EP4 in the bone marrow of the EP4A-stimulated group after transplantation is higher than that of the EP4+-Luc control group(0.164±0.004 vs.0.118±0.007,P=0.016).⑥Both CXCR4 mRNA and protein levels were higher in the EP4A-stimulated group(both P<0.05).Conclusion The EP4 gene was successfully cloned into human CD34+cells,leading to EP4 protein over-expression.EP4A may increase the directional homing efficiency of human CD34+hematopoietic cells to the bone marrow of recipient mice by promoting the expression of CXCR4.

黄丽君;李萍;甄佳怡;陈惠珍;许多荣

中山大学附属第一医院血液科,广东 广州 510080中山大学附属第一医院血液科,广东 广州 510080中山大学附属第一医院血液科,广东 广州 510080中山大学附属第一医院血液科,广东 广州 510080中山大学附属第一医院血液科,广东 广州 510080

人CD34+细胞慢病毒载体EP4 受体EP4 受体激动剂造血干细胞归巢

Human CD34+cellsLentiviral vectorEP4 receptorEP4 receptor agonistHematopoietic stem cell homing

《新医学》 2026 (4)

390-401,12

国家自然科学基金(82070183)

10.12464/j.issn.0253-9802.2025-0409

评论